Biomarkers for non-small cell lung cancer immunotherapy

The discovery of immune checkpoint inhibition has revolutionized the treatment of many solid malignancies, including non-small cell lung cancer (NSCLC). Immune checkpoint inhibitors (ICI) can restore the antitumor immune response by blocking the inhibition of T-cell activation. Anti-programmed death...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. A. Kharagezov, Yu. N. Lazutin, E. Yu. Zlatnik, A. B. Sagakyants, E. A. Mirzoyan, A. G. Milakin, O. N. Stateshny, A. V. Chubaryan, I. A. Leyman
Format:	Article
Language:	Russian
Published:	ANO "Perspective of oncology" 2021-09-01
Series:	Южно-Российский онкологический журнал
Subjects:	non-small cell lung cancer immunotherapy biomarkers checkpoint inhibitor anti-programmed deathligand 1 tumor mutation burden
Online Access:	https://www.cancersp.com/jour/article/view/112
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Biomarkers for non-small cell lung cancer immunotherapy

Similar Items